Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,262.56 89.32 0.55%
S&P 500 1,842.98 12.37 0.68%
NASDAQ 4,034.16 11.47 0.29%
Ticker Volume Price Price Delta
STOXX 50 3,124.54 33.02 1.07%
FTSE 100 6,570.88 29.27 0.45%
DAX 9,263.63 89.92 0.98%
Ticker Volume Price Price Delta
NIKKEI 14,417.68 420.87 3.01%
TOPIX 1,166.55 30.46 2.68%
HANG SENG 22,696.01 24.75 0.11%

Advanced Cell Technology to Announce Third Quarter Financial Results on Thursday, November 8th



  Advanced Cell Technology to Announce Third Quarter Financial Results on
  Thursday, November 8th

          Company to Hold Conference Call at 4:30 p.m. Eastern Time

Business Wire

MARLBOROUGH, Mass. -- November 05, 2012

Advanced Cell Technology, Inc. (“ACT”, OTCBB: ACTC or the “Company”), a leader
in the field of regenerative medicine announced today that it will release its
third quarter 2012 financial results on Thursday, November 8^th after the
market closes. The Company will hold a conference call at 4:30 p.m. EST that
day during which it will discuss its results and provide a corporate update.

Interested parties may dial (888) 264-3177 or 706-902-4345 using reference
conference ID number 90962762. The call will be available live and for replay
by webcast at: http://us.meeting-stream.com/advancedcelltechnology110812 .

About Advanced Cell Technology, Inc.

Advanced Cell Technology, Inc., is a biotechnology company applying cellular
technology in the field of regenerative medicine. For more information,
visit www.advancedcell.com.

Forward-Looking Statements

Statements in this news release regarding future financial and operating
results, future growth in research and development programs, potential
applications of our technology, opportunities for the company and any other
statements about the future expectations, beliefs, goals, plans, or prospects
expressed by management constitute forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995. Any
statements that are not statements of historical fact (including statements
containing the words “will,” “believes,” “plans,” “anticipates,” “expects,”
“estimates,” and similar expressions) should also be considered to be
forward-looking statements. There are a number of important factors that could
cause actual results or events to differ materially from those indicated by
such forward-looking statements, including: limited operating history, need
for future capital, risks inherent in the development and commercialization of
potential products, protection of our intellectual property, and economic
conditions generally. Additional information on potential factors that could
affect our results and other risks and uncertainties are detailed from time to
time in the company’s periodic reports, including the report on Form 10-K for
the year ended December 31, 2011. Forward-looking statements are based on the
beliefs, opinions, and expectations of the company’s management at the time
they are made, and the company does not assume any obligation to update its
forward-looking statements if those beliefs, opinions, expectations, or other
circumstances should change. Forward-looking statements are based on the
beliefs, opinions, and expectations of the company’s management at the time
they are made, and the company does not assume any obligation to update its
forward-looking statements if those beliefs, opinions, expectations, or other
circumstances should change. There can be no assurance that the Company’s
clinical trials will be successful.

Contact:

Investors:
CEOcast, Inc.
James Young, 212-732-4300
or
Press:
ACT Corporate Communications
Bill Douglass, 646-450-3615
or
Russo Partners
Martina Schwarzkopf, Ph.D., 212-845-4292
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement